electroCore, Inc. (ECOR) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Company Overview - electroCore, Inc. (ECOR) is expected to report a year-over-year increase in earnings due to higher revenues for the quarter ended December 2025, with a consensus outlook indicating a quarterly loss of $0.35 per share, representing a 12.5% improvement from the previous year [1][3] - Revenues are projected to reach $9.26 million, reflecting a 31.4% increase compared to the same quarter last year [3] Earnings Expectations - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that analysts have not significantly altered their outlook for the company [4] - The Most Accurate Estimate for electroCore is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -13.04%, suggesting a bearish sentiment among analysts regarding the company's earnings prospects [11] Earnings Surprise History - In the last reported quarter, electroCore was expected to post a loss of $0.36 per share but actually reported a loss of $0.40, resulting in a surprise of -11.11% [12] - Over the past four quarters, the company has only beaten consensus EPS estimates once [13] Industry Comparison - In contrast, Esperion Therapeutics (ESPR), a peer in the Zacks Medical - Drugs industry, is expected to post earnings of $0.23 per share for the same quarter, indicating a significant year-over-year change of +330% and projected revenues of $160.58 million, up 132.4% from the previous year [17][18] - Esperion's consensus EPS estimate has been revised up by 58.8% over the last 30 days, and it currently has an Earnings ESP of +37.63%, indicating a higher likelihood of beating the consensus EPS estimate [18][19]